Page 25 - Delaware Medical Journal - June 2016
P. 25
SCIENTIFIC ARTICLE
46. Hennedige AA, Jayasinghe J, Khajeh J, Macfarlane TV. Systematic review on
the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta. J Oral & Maxillofac Res. 2013;4.
47. Hegazy A, Kenawey M, Sochett E, Tile L, Cheung A, Howard A. Unusual femur stress fractures in children with osteogenesis imperfecta and intramedullary rods on long- term intravenous pamidronate therapy.
J Pediatr Orthop. 2015;1.
48. Orwoll ES, Shapiro J, Veith S, et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta.
J Clin Invest. 2014;124:491- 498.
49. Gatti D, Rossini M, Viapiana O, et al. Teriparatide treatment in adult patients with osteogenesis imperfecta type I.
Calcif Tissue Int. 2013;93:448-452.
50. Vahle JL, Long GG, Sandusky G, et al. Bone neoplasms in F344 rats given teriparatide [rhPTH(1–34)] are dependent on duration of treatment and dose.
Toxicol Pathol. 2004;32:426-438.
51. Zionts LE, Ebramzadeh E, Stott NS. Complications in the use of the Bailey-Dubow extensible nail.
Clin Orthop Relat Res. 1998;348:186-195.
52. Wilkinson JM, Scott BW, Clarke AM, Bell MJ. Surgical stabilization of the lower limb in
osteogenesis imperfecta using the Sheffield Telescopic Intramedullary Rod System.
J Bone Joint Surg Br. 1998;80:999-1004.
53. Mulpuri K, Joseph B. Intramedullary rodding in osteogenesis imperfecta.
J Pediatr Orthop. 2000;20:267-273.
54. Luhmann SJ, Sheridan JJ, Capelli AM, Schoenecker PL. Management of lower- extremity deformities in osteogenesis imperfecta with extensible intramedullary rod technique: A 20- year experience.
J Pediatr Orthop. 1998;18:88-94.
55. Ruck J, Dahan-Oliel N, Montpetit K, Rauch F, Fassier F. Fassier–Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: Functional outcomes at one year.
J Child Orthop. 2011;5:217-224.
56. Zeitlin L, Fassier F, Glorieux FH. Modern approach to children with osteogenesis imperfecta.
J Pediatr Orthop B. 2003;12:77-87.
57. Khoshhal KI, Ellis RD. Functional outcome of Sofield procedure in the upper limb in osteogenesis imperfecta.
J Pediatr Orthop. 2001;21:236-237.
58. Pan CH, Ma SC, Wu CT, Chen PQ. All pedicle screw fixation technique in correcting severe kyphoscoliosis in an osteogenesis imperfecta patient: A case report.
J Spinal Disord Tech. 2006;19:368-372.
59. Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S. Mesenchymal stem cells for bone repair and metabolic bone diseases.
Mayo Clin Proc. 2009;84:893-902.
60. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
61. Westgren M, Götherström C. Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta? Prenatal Diagnosis Prenat Diagn. 2015; 35:827-832.
62. Saban J, Zussman MA, Havey R, Patwardhan AG, Schneider GB, King D. Heterozygous oim mice exhibit a mild form of osteogenesisimperfecta.
Bone. 1996;19:575-579.
63. Sekiya H, Murakami T, Saito A, et al. Effects of the bisphosphonate risedronate on osteopenia in OASIS deficient mice.
J Bone Miner Metab. 2010;28:384-394.
64. Morello R, Bertin TK, Chen Y, et al. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006;127:291-304.
65. Firoozbakhsh K, Moneim MS, Yi IS,
Umeda Y, Theele D, Shahinpoor M. Smart intramedullary rod for correction of pediatric bone deformity: A preliminary study.
Clin Orthop Relat Res. 2004;424:194-201.

